Financial TimesShares in biotechs surge as two new human bird flu infections emergeMay 22Oliver BarnesBy Oliver Barnesmore_vert
STATReadout Newsletter: H5N1 bird flu vaccine, Cytokinetics, GileadMay 23Elaine ChenBy Elaine Chenmore_vert
Insider FinancialPlaying the Bird Flu Trade: CVAC BIXT NNVC GOVX DYAI NVAXMay 23Chris SandburgBy Chris Sandburgmore_vert
MorningstarModerna, CureVac, other vaccine stocks jump as new human bird-flu cases reported in U.S., AustraliaMay 22more_vert
ScienceCompanies start work on bird flu vaccines for cows—despite major hurdlesMay 20Jon CohenBy Jon Cohenmore_vert
University of Minnesota Twin CitiesHHS advances plan to produce 4.8 million H5N1 vaccine dosesMay 22Lisa SchnirringBy Lisa Schnirringmore_vert
STATQuestions and answers about ramping up H5N1 bird flu vaccine | STATMay 22Helen BranswellBy Helen Branswellmore_vert